Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGN | TEVA | BBIO | ||
| Company | Allergan Plc | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 193.01 | 33.80 | 73.38 | ||
| High | 193.38 | 34.43 | 73.71 | ||
| Low | 191.64 | 33.50 | 70.58 | ||
| Latest | 193.02 | 34.33 | 70.72 | ||
| Change | +0.03 | +0.22 | -3.21 | ||
| % Change | +0.02% | +0.64% | -4.34% | ||
| Volume | 12,442,600 | 6,875,471 | 3,652,700 | ||
| 20-Day Average Volume | 4,993,145 | 10,639,415 | 3,169,640 | ||
| Previous Close | 192.99 | 34.11 | 73.93 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 188.05 | 33.93 | 75.03 | ||
| 20-Day Raw Stochastic | 76.90% | 52.93% | 35.66% | ||
| 20-Day Relative Strength | 59.14 | 62.08 | 45.01 | ||
| Weighted Alpha | +28.20 | +129.90 | +91.64 | ||
| Today's Opinion | 72% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 24% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.73% since 05/01/20 | +0.06% since 02/11/26 | -3.56% since 02/11/26 | ||
| Low | 187.75 on 05/04/20 | 33.50 on 02/19/26 | 70.58 on 02/19/26 | ||
| High | 196.45 on 05/06/20 | 35.32 on 02/17/26 | 84.94 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +6.59% since 04/08/20 | +8.09% since 01/16/26 | -7.26% since 01/16/26 | ||
| Low | 181.21 on 04/09/20 | 30.70 on 01/20/26 | 62.84 on 02/05/26 | ||
| High | 196.45 on 05/06/20 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | ||
| 3-Month | |||||
| %Chg | -2.05% since 02/07/20 | +40.47% since 11/19/25 | +7.90% since 11/19/25 | ||
| Low | 158.67 on 03/18/20 | 24.01 on 11/21/25 | 62.84 on 02/05/26 | ||
| High | 202.21 on 02/12/20 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | ||
| 6-Month | |||||
| %Chg | +6.48% since 11/08/19 | +95.50% since 08/19/25 | +44.59% since 08/19/25 | ||
| Low | 158.67 on 03/18/20 | 17.33 on 08/20/25 | 46.81 on 08/25/25 | ||
| High | 202.21 on 02/12/20 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 63,503,972 | 39,220,124 | 14,246,975 | ||
| Shares Outstanding, K | 329,002 | 1,149,813 | 192,709 | ||
| Annual Sales | 16,088,900,000 | 17,258,000,000 | 221,900,000 | ||
| Annual Net Income | -5,271,000,000 | 1,411,000,000 | -535,760,000 | ||
| Last Quarter Sales | 4,351,000,000 | 4,711,000,000 | 120,700,000 | ||
| Last Quarter Net Income | -317,200,000 | 481,000,000 | -182,740,000 | ||
| 60-Month Beta | 1.20 | 0.70 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.22 on 02/10/20 | 0.96 on 01/28/26 | -0.95 on 10/29/25 | ||
| Latest Earnings Date | 05/07/20 | 05/06/26 | 02/24/26 | ||
| Most Recent Dividend | 0.740 on 04/15/20 | 0.072 on 11/27/17 | N/A | ||
| Next Ex-Dividends Date | 04/15/20 | 11/27/17 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.94 | 12.25 | 0.00 | ||